Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-Linking Assisted Infection Reduction (CLAIR)
NCT02570321Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2015
- Primary completion
- Jun 2018
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial in infectious keratitis (IK) and corneal ulcer (6 arms), sponsored by University of California, San Francisco. Primary endpoint: Microbiological Cure on Repeat Culture at 24 hours. Started Nov 2015; status: completed.
02
Conditions
infectious keratitis (IK)corneal ulcer
Beyond the preview
Go deeper on NCT02570321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570321.